Genomic Epidemiology Branch (GEB)

The Genomic Epidemiology Branch (GEB) focuses on factors that influence personal susceptibility to cancer, such as genetic, epigenetic, immunological, and hormonal biological pathways; and social, cultural, and race/ethnic factors.

GEB's mission is to plan, develop, direct, coordinate, and evaluate:

  • A comprehensive program of epidemiologic research in the etiology of cancer in human populations related to host (i.e., personal) susceptibility factors such as genetic, epigenetic, immunological and hormonal biological pathways; and social, cultural, and race/ethnicity factors;
  • A program of epidemiologic research to study differences in cancer susceptibility and risk in individuals and populations and the multiple environmental and genetic factors that jointly contribute to cancer, with the ultimate goal of elucidating the etiology of cancer;
  • A program of extramural epidemiologic research to evaluate the association of and magnitude of cancer risk associated with biomarkers of host susceptibility such as physiological status or function; and
  • Research resources, infrastructures, and consortia with a focus on personal susceptibility factors to facilitate and maximize the scientific potential of cancer epidemiology research.

Its mission also is to disseminate findings from the research supported by the Branch to the public, health care professionals, scientists engaged in cancer control, and the public health community.


GEB Staff

Branch Name / Title / Contact Info Interest Areas
GEB

Gillanders, Elizabeth M., Ph.D.
Branch Chief

Phone: (240) 276-6764
Email: lgilland@mail.nih.gov

  • Genetic epidemiology of cancer
GEB

Brignole, Katy, M.Sc.
Cancer Research Training Award Fellow

Phone: (240) 276-5612
Email: brignolekr@mail.nih.gov

  • Global health
  • Health disparities
  • Risk and the role of environment
  • Behavior
  • Genes in disease
  • Spatial-temporal epidemiology
  • Cervical cancer
  • Infectious agents and cancer
  • Mixed methods research
  • Appropriate low cost technologies for low resource settings
GEB

Caga-anan, Charlisse, J.D.
Program Director

Phone: (240) 276-6738
Email: cagaananef@mail.nih.gov

  • Ethics of genomics and genetics research
  • Health law and bioethics
GEB

Carrick, Danielle Mercatante, Ph.D., M.H.S.
Program Director

Phone: (240) 276-6749
Email: carrick@mail.nih.gov

  • Immunology, infectious diseases, and autoimmune diseases associated with cancer risk
  • Pharmacoepidemiology and pharmacogenomics
  • Biospecimen research
  • Functional genomics
GEB

Chenjo, Charmeeka
Program Support Assistant

Phone: (240) 276-6739
Email: chenjoc@mail.nih.gov

  • Not Available
GEB

Green, Tiffany, M.H.S., M.P.H.
Contractor, Program Analyst

Phone: (240) 428-0142
Email: greentif@mail.nih.gov

  • Ethical and social issues surrounding advances in the genetic epidemiology of cancer and infectious diseases
GEB

Martin, Damali N., Ph.D., M.P.H.
Program Director

Phone: (240) 276-6746
Email: martinda@mail.nih.gov

  • Health disparities in populations of African descent, globally
  • Global Health and cancer epidemiology with focus on Sub-Saharan Africa and the Caribbean
GEB

Mechanic, Leah E., Ph.D., M.P.H.
Program Director

Phone: (240) 276-6847
Email: mechanil@mail.nih.gov

  • Gene-gene and gene-environment interactions
  • Biospecimen science
  • Molecular epidemiology of lung cancer
  • Hematological malignancies
  • Endometrial cancer
GEB

Nelson, Stefanie A., Ph.D.
Program Director

Phone: (240) 276-6944
Email: nelsons@mail.nih.gov

  • Genetic differences affecting cancer risk and response to treatment
  • Understanding the function of cancer risk variants
  • Interactions between the germline and somatic cancer genomes
GEB

Tingle, Sharna, M.P.H.
Cancer Research Training Award Fellow

Phone: (240) 276-6934
Email: tinglesr@mail.nih.gov

  • Health policy
  • Bioethics
  • Public health genomics
GEB

Zanetti, Krista A., Ph.D., M.P.H., R.D.
Program Director

Phone: (240) 276-6843
Email: zanettik@mail.nih.gov

  • Metabolomics
  • Biological determinants of health disparities associated with cancer

Return to Top